Encision's newest disposable laparoscopic instruments will give surgeons
precise fingertip power control during laparoscopic procedures while delivering patient protection from unseen stray energy burns - a first in
the healthcare industry
BOULDER, Colo., March 31 /PRNewswire-FirstCall/ -- Beginning this week, hospitals will have a unique opportunity to offer surgeons greater control and precision during surgeries while simultaneously delivering increased safety to patients. Encision Inc. (Amex: ECI) ("Encision" or the "Company") announced today that it is launching its new disposable hand-activated fixed-tip electrode line of laparoscopic instruments.
The new disposable fixed-tip electrode line features hand activation for surgeons who prefer to energize the electrode via a fingertip switch rather than pressing their foot on a foot pedal.
"The introduction of our disposable hand switching, fixed-tip electrode line is a major step in fulfilling our goal of presenting customers with both disposable and reusable options in the laparoscopic instruments they prefer," said Jack Serino, Encision President & CEO.
"We are pleased to provide the ultimate in patient safety with our AEM(R) technology along with best of class ergonomic instruments. Besides offering surgeons AEM at their fingertips, the new disposable fixed-tip electrodes feature an easy to reach rotation knob with a locking feature and a comfort grip handle. Hand-activated instruments represent a growing market segment that our Company is pleased to participate in with this new product line."
The new product line consists of a disposable handle with integral cord and disposable electrodes available in six popular tip styles. The disposable electrodes are available in both 35cm lengths for routine procedures and 45cm lengths for bariatric procedures.
Encision Inc. designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM(R) Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery. For further information about Encision's line of laparoscopic instruments, please visit http://www.encision.com
In accordance with the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, the Company notes that statements in this
press release and elsewhere that look forward in time, which include
everything other than historical information, involve risks and
uncertainties that may cause actual results to differ materially from those
indicated by the forward-looking statements. Factors that could cause the
Company's actual results to differ materially include, among others, its
ability to increase net sales through the Company's distribution channels,
insufficient quantity of new account conversions, insufficient cash to fund
operations, scale up production to meet delivery obligations, delay in
developing new products and receiving FDA approval for such new products
and other factors discussed in the Company's filings with the Securities
and Exchange Commission.
CONTACT: Marcia McHaffie
|SOURCE Encision Inc.|
Copyright©2008 PR Newswire.
All rights reserved